JACIE completed the first-ever inspection under its third edition Immune Effector Cells (IEC) Standards at Guy’s and St Thomas’ NHS Foundation Trust in Barcelona as the field expands certification pathways beyond transplant centers. The initial inspection under the updated IEC framework is positioned as a test of the robustness of the new standards. The development matters for service providers and sponsors seeking broader sites for immune effector cell therapies, including settings that extend beyond traditional transplant workflows. By demonstrating the inspection model can be executed in a major NHS center, JACIE is effectively widening the compliance playbook. Overall, the update signals an incremental regulatory infrastructure shift intended to support scale-out of cellular therapy delivery across more kinds of centers.